TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 61.10
+1.60 (2.69%)
Oct 16, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 16.69 billion as of October 16, 2026. It is the 14,413th most valuable company in the world and the 508th biggest in Taiwan. Its market cap has decreased by 13.70% in one year.
Market Cap
16.69B
Enterprise Value
15.57B
Revenue
619.49M
Global Rank
Country Rank
#508 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 16.69B, an increase of 546.89%. That is a compound annual growth rate of 12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 16.69B | -0.16% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.74B |
| CHO Pharma | 22.90B |
| Sunmax Biotechnology | 21.51B |
| Medigen Vaccine Biologics | 17.33B |
| Ever Supreme Bio Technology | 15.81B |
| Steminent Biotherapeutics | 15.75B |
| Gongwin Biopharm Holdings | 15.32B |
| EirGenix | 15.26B |